Feedback / Questions
Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
nanatinostat (VRx-3996) - Viracta Therap
https://www.prnewswire.com/news-releases/viracta-therapeutics-reports-second-quarter-2022-financial-results-and-recent-updates-301602048.html
Aug 9, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next